Baidu
map

IBM Watson Health将与FDA协作研究,如何借助区块链技术实现医疗保健数据的安全交换

2017-01-20 王晓行 动脉网

近日,IBM Watson人工智能医疗保健解决方案部门——IBM Watson Health已与美国食品和药物管理局 (FDA) 签署了一项研究计划,旨在如何借助区块链技术实现医疗保健数据的安全、高效和可扩展性。 IBM和FDA将联合探索如何交换来自多种来源的所有者介入数据,例如电子医疗记录、临床试验、基因数据,以及来自移动设备、可穿戴设备和物联网的医疗保健数据等。该项目初期的关注重点是

近日,IBM Watson人工智能医疗保健解决方案部门——IBM Watson Health已与美国食品和药物管理局 (FDA) 签署了一项研究计划,旨在如何借助区块链技术实现医疗保健数据的安全、高效和可扩展性。

IBM和FDA将联合探索如何交换来自多种来源的所有者介入数据,例如电子医疗记录、临床试验、基因数据,以及来自移动设备、可穿戴设备和物联网的医疗保健数据等。该项目初期的关注重点是与肿瘤相关的数据。


什么是区块链?

区块链(Blockchain)是分布式数据存储、点对点传输、共识机制、加密算法等计算机技术的新型应用模式。也是是比特币的一个重要概念,区块链诞生自中本聪的比特币,自2009年以来,出现了各种各样的类比特币的数字货币,都是基于公有区块链的。

本质上是一个去中心化的数据库,同时作为比特币的底层技术。区块链是一串使用密码学方法相关联产生的数据块,每一个数据块中包含了一次比特币网络交易的信息,用于验证其信息的有效性(防伪)和生成下一个区块


区块链核心技术创新是:分布式记账、对称加密和授权技术,存储在区块链上的交易信息是公开的,但是账户身份信息是高度加密的,只有在数据拥有者授权的情况下才能访问到,从而保证了数据的安全和个人的隐私。共识机制和智能合约。具有去中心化、开放性、自治性、信息不可篡改和匿名性等特点。

目前区块链已经发展到第三代,区块链2.0 就应用到了数字资产和智能合约,到区块链3.0就形成了区块链自洽组织、区块链自洽公司,应用到了科学,医疗,教育etc,人工智能。

安全的去中心化框架

IBM在区块链技术领域已经深耕已久,IBM是Linux Foundation超级账本项目的创立成员之一。

电子病历EMR包含大量数据,比如人口统计、医疗和基因信息,是生物医学研究的数据库。但是因为其中的数据都是高度敏感的,限制了研究用途的数据共享,比如医疗诊断。

IBM研究员在分布式账本上记录所有审计轨迹,可以保证数据交换的透明性和可靠性。IBM称:“如果研究员和医疗保健服务供应商可以获得患者数据的全部信息,就可以实现变革性医疗保健解决方案”。

IBM最近调查了200位医疗保健行业高管,包括保险商和服务商,调查显示,对于医疗保健行业而言,超过70%的行业领导者预计,区块链技术的最大益处在于有助于管理临床试验记录、监管合规性和医疗/健康记录。

IBM和FDA将共同探索区块链框架如何通过支持临床试验数据,以及通过“真实世界”的证据数据等广泛数据类型之间信息交换的重要使用案例,从而推动公共健康水平的发展。

该协作还包括通过新的方式充分发掘当今生物医学和医疗保健领域海量多样化数据的价值。借助安全的所有者介入数据共享生态系统,它将有助于推动新发现并改善公共健康。举例来说,来自可穿戴设备和互联设备的病患数据,可帮助医师和护理人员更好地管理人群健康。

随着区块链技术在医疗保健领域的前景日益清晰,IBM将致力于定义和构建相应的技术解决方案,进而打造一个可扩展的、去中心化数据共享生态系统。

在医疗应用中,区块链技术提供了一个安全的去中心化框架,有助于实现可控的病患信息共享。区块链是药品电子履历、供应链领域的自然解决方案,也是药品制造商、分销商和药店应对他们所面临的产品完整性挑战的极好的处理办法。通过额外的开发,可使区块链变为不可更改的分布式病患记录,这些记录可确保安全,实现轻松共享,进而加速药物研发流程。

对于临床试验的所有参与方来说,基于区块链的流程有助于改善完整性、安全性和透明度,进而提升试验赞助商、调查人员、CRO与病患之间的复杂互动。预计,FDA与 IBM Watson Health进行的尝试,将会给区块链技术在生命科学领域的运用孕育出大量的、高价值的其他用例。

病患安全的分享健康数据

EMR技术应用有利于医疗服务提供方与保险方的电子数据交换;还可以提高服务和流程的质量。EMR数据还有助于提供大规模低成本的医疗、药品分析数据。

在以往,大规模的健康数据共享往往会因为数据交换过程中的数据安全、病患隐私泄露问题而受到诸多局限。医疗数据的安全共享有助于新药品研发,是实现个性化医疗的关键。

美国政府为了完善国内的医疗保健数据共享系统,奥巴马政府花费500亿美元实施EMR;然而尽管采用了EMR,很多机构无法保证数据共享的安全性,即使是机构内部的医院和诊所之间都无法保证安全。IBM Watson Health与FDA签署了两年的联合开发协议,希望利用区块链技术完善医学研究等项目中的患者数据共享。

如果医疗保健研究人员和提供商能够全方位地访问病患数据,就有望实现医疗保健解决方案的转型。就目前而言,病患对其健康数据的访问非常有限,也无法与研究人员或提供商轻松分享此类数据。

如果病患能够安全地分享他们的健康数据,无论是处于研究目的还是在各个医疗保健提供商之间共享数据,均有助于推动医疗保健业的重大进步。借助区块链技术,我们将有机会实现这一点,因为该技术的宗旨就是推动各个组织以更加相互信赖的方式进行协作。

IBM Watson Health和FDA计划明年年初公布该项目研究结果。

免责声明:本文内容和图片由作者依据IBM官方微信和互联网内容编辑得来,如涉及版权问题,请与作者联系。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2068224, encodeId=7d5c20682243e, content=<a href='/topic/show?id=e94b298327' target=_blank style='color:#2F92EE;'>#ATS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2983, encryptionId=e94b298327, topicName=ATS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Mon Jul 31 14:11:00 CST 2017, time=2017-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719640, encodeId=6f3c1e19640d0, content=<a href='/topic/show?id=1dc333e5881' target=_blank style='color:#2F92EE;'>#区块链#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33758, encryptionId=1dc333e5881, topicName=区块链)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a532785563, createdName=zzc2222, createdTime=Mon Sep 04 14:11:00 CST 2017, time=2017-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1991384, encodeId=e36d1991384ea, content=<a href='/topic/show?id=f51f1861818' target=_blank style='color:#2F92EE;'>#Watson#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18618, encryptionId=f51f1861818, topicName=Watson)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e30378, createdName=caobinglei8079, createdTime=Sat Jan 28 02:11:00 CST 2017, time=2017-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861076, encodeId=c5c818610e6b8, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Nov 07 04:11:00 CST 2017, time=2017-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=172047, encodeId=0ea01e2047d8, content=人工智能是亮点, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=635d2010152, createdName=1e1ea464m97(暂无匿称), createdTime=Sun Jan 22 22:53:41 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=172036, encodeId=85aa1e203688, content=学到了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d32a1717978, createdName=1debbfffm06(暂无匿称), createdTime=Sun Jan 22 22:07:38 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489929, encodeId=e91614899294c, content=<a href='/topic/show?id=f91c93134e' target=_blank style='color:#2F92EE;'>#IBM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9313, encryptionId=f91c93134e, topicName=IBM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0288649873, createdName=tulenzi, createdTime=Sun Jan 22 05:11:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525862, encodeId=33551525862f1, content=<a href='/topic/show?id=22a03480efa' target=_blank style='color:#2F92EE;'>#医疗保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34807, encryptionId=22a03480efa, topicName=医疗保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eb511671747, createdName=drj2007, createdTime=Sun Jan 22 05:11:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621592, encodeId=0b99162159265, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sun Jan 22 05:11:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171624, encodeId=8b691e1624e8, content=区块链(Blockchain)是分布式数据存储、点对点传输、共识机制、加密算法等计算机技术的新型应用模式, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri Jan 20 16:03:17 CST 2017, time=2017-01-20, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2068224, encodeId=7d5c20682243e, content=<a href='/topic/show?id=e94b298327' target=_blank style='color:#2F92EE;'>#ATS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2983, encryptionId=e94b298327, topicName=ATS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Mon Jul 31 14:11:00 CST 2017, time=2017-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719640, encodeId=6f3c1e19640d0, content=<a href='/topic/show?id=1dc333e5881' target=_blank style='color:#2F92EE;'>#区块链#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33758, encryptionId=1dc333e5881, topicName=区块链)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a532785563, createdName=zzc2222, createdTime=Mon Sep 04 14:11:00 CST 2017, time=2017-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1991384, encodeId=e36d1991384ea, content=<a href='/topic/show?id=f51f1861818' target=_blank style='color:#2F92EE;'>#Watson#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18618, encryptionId=f51f1861818, topicName=Watson)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e30378, createdName=caobinglei8079, createdTime=Sat Jan 28 02:11:00 CST 2017, time=2017-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861076, encodeId=c5c818610e6b8, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Nov 07 04:11:00 CST 2017, time=2017-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=172047, encodeId=0ea01e2047d8, content=人工智能是亮点, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=635d2010152, createdName=1e1ea464m97(暂无匿称), createdTime=Sun Jan 22 22:53:41 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=172036, encodeId=85aa1e203688, content=学到了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d32a1717978, createdName=1debbfffm06(暂无匿称), createdTime=Sun Jan 22 22:07:38 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489929, encodeId=e91614899294c, content=<a href='/topic/show?id=f91c93134e' target=_blank style='color:#2F92EE;'>#IBM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9313, encryptionId=f91c93134e, topicName=IBM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0288649873, createdName=tulenzi, createdTime=Sun Jan 22 05:11:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525862, encodeId=33551525862f1, content=<a href='/topic/show?id=22a03480efa' target=_blank style='color:#2F92EE;'>#医疗保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34807, encryptionId=22a03480efa, topicName=医疗保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eb511671747, createdName=drj2007, createdTime=Sun Jan 22 05:11:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621592, encodeId=0b99162159265, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sun Jan 22 05:11:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171624, encodeId=8b691e1624e8, content=区块链(Blockchain)是分布式数据存储、点对点传输、共识机制、加密算法等计算机技术的新型应用模式, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri Jan 20 16:03:17 CST 2017, time=2017-01-20, status=1, ipAttribution=)]
    2017-09-04 zzc2222
  3. [GetPortalCommentsPageByObjectIdResponse(id=2068224, encodeId=7d5c20682243e, content=<a href='/topic/show?id=e94b298327' target=_blank style='color:#2F92EE;'>#ATS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2983, encryptionId=e94b298327, topicName=ATS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Mon Jul 31 14:11:00 CST 2017, time=2017-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719640, encodeId=6f3c1e19640d0, content=<a href='/topic/show?id=1dc333e5881' target=_blank style='color:#2F92EE;'>#区块链#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33758, encryptionId=1dc333e5881, topicName=区块链)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a532785563, createdName=zzc2222, createdTime=Mon Sep 04 14:11:00 CST 2017, time=2017-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1991384, encodeId=e36d1991384ea, content=<a href='/topic/show?id=f51f1861818' target=_blank style='color:#2F92EE;'>#Watson#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18618, encryptionId=f51f1861818, topicName=Watson)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e30378, createdName=caobinglei8079, createdTime=Sat Jan 28 02:11:00 CST 2017, time=2017-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861076, encodeId=c5c818610e6b8, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Nov 07 04:11:00 CST 2017, time=2017-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=172047, encodeId=0ea01e2047d8, content=人工智能是亮点, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=635d2010152, createdName=1e1ea464m97(暂无匿称), createdTime=Sun Jan 22 22:53:41 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=172036, encodeId=85aa1e203688, content=学到了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d32a1717978, createdName=1debbfffm06(暂无匿称), createdTime=Sun Jan 22 22:07:38 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489929, encodeId=e91614899294c, content=<a href='/topic/show?id=f91c93134e' target=_blank style='color:#2F92EE;'>#IBM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9313, encryptionId=f91c93134e, topicName=IBM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0288649873, createdName=tulenzi, createdTime=Sun Jan 22 05:11:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525862, encodeId=33551525862f1, content=<a href='/topic/show?id=22a03480efa' target=_blank style='color:#2F92EE;'>#医疗保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34807, encryptionId=22a03480efa, topicName=医疗保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eb511671747, createdName=drj2007, createdTime=Sun Jan 22 05:11:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621592, encodeId=0b99162159265, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sun Jan 22 05:11:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171624, encodeId=8b691e1624e8, content=区块链(Blockchain)是分布式数据存储、点对点传输、共识机制、加密算法等计算机技术的新型应用模式, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri Jan 20 16:03:17 CST 2017, time=2017-01-20, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2068224, encodeId=7d5c20682243e, content=<a href='/topic/show?id=e94b298327' target=_blank style='color:#2F92EE;'>#ATS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2983, encryptionId=e94b298327, topicName=ATS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Mon Jul 31 14:11:00 CST 2017, time=2017-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719640, encodeId=6f3c1e19640d0, content=<a href='/topic/show?id=1dc333e5881' target=_blank style='color:#2F92EE;'>#区块链#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33758, encryptionId=1dc333e5881, topicName=区块链)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a532785563, createdName=zzc2222, createdTime=Mon Sep 04 14:11:00 CST 2017, time=2017-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1991384, encodeId=e36d1991384ea, content=<a href='/topic/show?id=f51f1861818' target=_blank style='color:#2F92EE;'>#Watson#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18618, encryptionId=f51f1861818, topicName=Watson)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e30378, createdName=caobinglei8079, createdTime=Sat Jan 28 02:11:00 CST 2017, time=2017-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861076, encodeId=c5c818610e6b8, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Nov 07 04:11:00 CST 2017, time=2017-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=172047, encodeId=0ea01e2047d8, content=人工智能是亮点, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=635d2010152, createdName=1e1ea464m97(暂无匿称), createdTime=Sun Jan 22 22:53:41 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=172036, encodeId=85aa1e203688, content=学到了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d32a1717978, createdName=1debbfffm06(暂无匿称), createdTime=Sun Jan 22 22:07:38 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489929, encodeId=e91614899294c, content=<a href='/topic/show?id=f91c93134e' target=_blank style='color:#2F92EE;'>#IBM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9313, encryptionId=f91c93134e, topicName=IBM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0288649873, createdName=tulenzi, createdTime=Sun Jan 22 05:11:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525862, encodeId=33551525862f1, content=<a href='/topic/show?id=22a03480efa' target=_blank style='color:#2F92EE;'>#医疗保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34807, encryptionId=22a03480efa, topicName=医疗保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eb511671747, createdName=drj2007, createdTime=Sun Jan 22 05:11:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621592, encodeId=0b99162159265, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sun Jan 22 05:11:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171624, encodeId=8b691e1624e8, content=区块链(Blockchain)是分布式数据存储、点对点传输、共识机制、加密算法等计算机技术的新型应用模式, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri Jan 20 16:03:17 CST 2017, time=2017-01-20, status=1, ipAttribution=)]
    2017-11-07 shizhenshan
  5. [GetPortalCommentsPageByObjectIdResponse(id=2068224, encodeId=7d5c20682243e, content=<a href='/topic/show?id=e94b298327' target=_blank style='color:#2F92EE;'>#ATS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2983, encryptionId=e94b298327, topicName=ATS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Mon Jul 31 14:11:00 CST 2017, time=2017-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719640, encodeId=6f3c1e19640d0, content=<a href='/topic/show?id=1dc333e5881' target=_blank style='color:#2F92EE;'>#区块链#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33758, encryptionId=1dc333e5881, topicName=区块链)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a532785563, createdName=zzc2222, createdTime=Mon Sep 04 14:11:00 CST 2017, time=2017-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1991384, encodeId=e36d1991384ea, content=<a href='/topic/show?id=f51f1861818' target=_blank style='color:#2F92EE;'>#Watson#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18618, encryptionId=f51f1861818, topicName=Watson)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e30378, createdName=caobinglei8079, createdTime=Sat Jan 28 02:11:00 CST 2017, time=2017-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861076, encodeId=c5c818610e6b8, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Nov 07 04:11:00 CST 2017, time=2017-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=172047, encodeId=0ea01e2047d8, content=人工智能是亮点, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=635d2010152, createdName=1e1ea464m97(暂无匿称), createdTime=Sun Jan 22 22:53:41 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=172036, encodeId=85aa1e203688, content=学到了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d32a1717978, createdName=1debbfffm06(暂无匿称), createdTime=Sun Jan 22 22:07:38 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489929, encodeId=e91614899294c, content=<a href='/topic/show?id=f91c93134e' target=_blank style='color:#2F92EE;'>#IBM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9313, encryptionId=f91c93134e, topicName=IBM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0288649873, createdName=tulenzi, createdTime=Sun Jan 22 05:11:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525862, encodeId=33551525862f1, content=<a href='/topic/show?id=22a03480efa' target=_blank style='color:#2F92EE;'>#医疗保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34807, encryptionId=22a03480efa, topicName=医疗保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eb511671747, createdName=drj2007, createdTime=Sun Jan 22 05:11:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621592, encodeId=0b99162159265, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sun Jan 22 05:11:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171624, encodeId=8b691e1624e8, content=区块链(Blockchain)是分布式数据存储、点对点传输、共识机制、加密算法等计算机技术的新型应用模式, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri Jan 20 16:03:17 CST 2017, time=2017-01-20, status=1, ipAttribution=)]
    2017-01-22 1e1ea464m97(暂无匿称)

    人工智能是亮点

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2068224, encodeId=7d5c20682243e, content=<a href='/topic/show?id=e94b298327' target=_blank style='color:#2F92EE;'>#ATS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2983, encryptionId=e94b298327, topicName=ATS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Mon Jul 31 14:11:00 CST 2017, time=2017-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719640, encodeId=6f3c1e19640d0, content=<a href='/topic/show?id=1dc333e5881' target=_blank style='color:#2F92EE;'>#区块链#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33758, encryptionId=1dc333e5881, topicName=区块链)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a532785563, createdName=zzc2222, createdTime=Mon Sep 04 14:11:00 CST 2017, time=2017-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1991384, encodeId=e36d1991384ea, content=<a href='/topic/show?id=f51f1861818' target=_blank style='color:#2F92EE;'>#Watson#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18618, encryptionId=f51f1861818, topicName=Watson)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e30378, createdName=caobinglei8079, createdTime=Sat Jan 28 02:11:00 CST 2017, time=2017-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861076, encodeId=c5c818610e6b8, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Nov 07 04:11:00 CST 2017, time=2017-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=172047, encodeId=0ea01e2047d8, content=人工智能是亮点, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=635d2010152, createdName=1e1ea464m97(暂无匿称), createdTime=Sun Jan 22 22:53:41 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=172036, encodeId=85aa1e203688, content=学到了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d32a1717978, createdName=1debbfffm06(暂无匿称), createdTime=Sun Jan 22 22:07:38 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489929, encodeId=e91614899294c, content=<a href='/topic/show?id=f91c93134e' target=_blank style='color:#2F92EE;'>#IBM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9313, encryptionId=f91c93134e, topicName=IBM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0288649873, createdName=tulenzi, createdTime=Sun Jan 22 05:11:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525862, encodeId=33551525862f1, content=<a href='/topic/show?id=22a03480efa' target=_blank style='color:#2F92EE;'>#医疗保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34807, encryptionId=22a03480efa, topicName=医疗保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eb511671747, createdName=drj2007, createdTime=Sun Jan 22 05:11:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621592, encodeId=0b99162159265, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sun Jan 22 05:11:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171624, encodeId=8b691e1624e8, content=区块链(Blockchain)是分布式数据存储、点对点传输、共识机制、加密算法等计算机技术的新型应用模式, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri Jan 20 16:03:17 CST 2017, time=2017-01-20, status=1, ipAttribution=)]
    2017-01-22 1debbfffm06(暂无匿称)

    学到了,谢谢

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2068224, encodeId=7d5c20682243e, content=<a href='/topic/show?id=e94b298327' target=_blank style='color:#2F92EE;'>#ATS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2983, encryptionId=e94b298327, topicName=ATS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Mon Jul 31 14:11:00 CST 2017, time=2017-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719640, encodeId=6f3c1e19640d0, content=<a href='/topic/show?id=1dc333e5881' target=_blank style='color:#2F92EE;'>#区块链#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33758, encryptionId=1dc333e5881, topicName=区块链)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a532785563, createdName=zzc2222, createdTime=Mon Sep 04 14:11:00 CST 2017, time=2017-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1991384, encodeId=e36d1991384ea, content=<a href='/topic/show?id=f51f1861818' target=_blank style='color:#2F92EE;'>#Watson#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18618, encryptionId=f51f1861818, topicName=Watson)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e30378, createdName=caobinglei8079, createdTime=Sat Jan 28 02:11:00 CST 2017, time=2017-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861076, encodeId=c5c818610e6b8, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Nov 07 04:11:00 CST 2017, time=2017-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=172047, encodeId=0ea01e2047d8, content=人工智能是亮点, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=635d2010152, createdName=1e1ea464m97(暂无匿称), createdTime=Sun Jan 22 22:53:41 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=172036, encodeId=85aa1e203688, content=学到了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d32a1717978, createdName=1debbfffm06(暂无匿称), createdTime=Sun Jan 22 22:07:38 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489929, encodeId=e91614899294c, content=<a href='/topic/show?id=f91c93134e' target=_blank style='color:#2F92EE;'>#IBM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9313, encryptionId=f91c93134e, topicName=IBM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0288649873, createdName=tulenzi, createdTime=Sun Jan 22 05:11:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525862, encodeId=33551525862f1, content=<a href='/topic/show?id=22a03480efa' target=_blank style='color:#2F92EE;'>#医疗保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34807, encryptionId=22a03480efa, topicName=医疗保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eb511671747, createdName=drj2007, createdTime=Sun Jan 22 05:11:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621592, encodeId=0b99162159265, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sun Jan 22 05:11:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171624, encodeId=8b691e1624e8, content=区块链(Blockchain)是分布式数据存储、点对点传输、共识机制、加密算法等计算机技术的新型应用模式, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri Jan 20 16:03:17 CST 2017, time=2017-01-20, status=1, ipAttribution=)]
    2017-01-22 tulenzi
  8. [GetPortalCommentsPageByObjectIdResponse(id=2068224, encodeId=7d5c20682243e, content=<a href='/topic/show?id=e94b298327' target=_blank style='color:#2F92EE;'>#ATS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2983, encryptionId=e94b298327, topicName=ATS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Mon Jul 31 14:11:00 CST 2017, time=2017-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719640, encodeId=6f3c1e19640d0, content=<a href='/topic/show?id=1dc333e5881' target=_blank style='color:#2F92EE;'>#区块链#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33758, encryptionId=1dc333e5881, topicName=区块链)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a532785563, createdName=zzc2222, createdTime=Mon Sep 04 14:11:00 CST 2017, time=2017-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1991384, encodeId=e36d1991384ea, content=<a href='/topic/show?id=f51f1861818' target=_blank style='color:#2F92EE;'>#Watson#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18618, encryptionId=f51f1861818, topicName=Watson)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e30378, createdName=caobinglei8079, createdTime=Sat Jan 28 02:11:00 CST 2017, time=2017-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861076, encodeId=c5c818610e6b8, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Nov 07 04:11:00 CST 2017, time=2017-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=172047, encodeId=0ea01e2047d8, content=人工智能是亮点, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=635d2010152, createdName=1e1ea464m97(暂无匿称), createdTime=Sun Jan 22 22:53:41 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=172036, encodeId=85aa1e203688, content=学到了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d32a1717978, createdName=1debbfffm06(暂无匿称), createdTime=Sun Jan 22 22:07:38 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489929, encodeId=e91614899294c, content=<a href='/topic/show?id=f91c93134e' target=_blank style='color:#2F92EE;'>#IBM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9313, encryptionId=f91c93134e, topicName=IBM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0288649873, createdName=tulenzi, createdTime=Sun Jan 22 05:11:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525862, encodeId=33551525862f1, content=<a href='/topic/show?id=22a03480efa' target=_blank style='color:#2F92EE;'>#医疗保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34807, encryptionId=22a03480efa, topicName=医疗保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eb511671747, createdName=drj2007, createdTime=Sun Jan 22 05:11:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621592, encodeId=0b99162159265, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sun Jan 22 05:11:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171624, encodeId=8b691e1624e8, content=区块链(Blockchain)是分布式数据存储、点对点传输、共识机制、加密算法等计算机技术的新型应用模式, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri Jan 20 16:03:17 CST 2017, time=2017-01-20, status=1, ipAttribution=)]
  9. [GetPortalCommentsPageByObjectIdResponse(id=2068224, encodeId=7d5c20682243e, content=<a href='/topic/show?id=e94b298327' target=_blank style='color:#2F92EE;'>#ATS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2983, encryptionId=e94b298327, topicName=ATS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Mon Jul 31 14:11:00 CST 2017, time=2017-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719640, encodeId=6f3c1e19640d0, content=<a href='/topic/show?id=1dc333e5881' target=_blank style='color:#2F92EE;'>#区块链#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33758, encryptionId=1dc333e5881, topicName=区块链)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a532785563, createdName=zzc2222, createdTime=Mon Sep 04 14:11:00 CST 2017, time=2017-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1991384, encodeId=e36d1991384ea, content=<a href='/topic/show?id=f51f1861818' target=_blank style='color:#2F92EE;'>#Watson#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18618, encryptionId=f51f1861818, topicName=Watson)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e30378, createdName=caobinglei8079, createdTime=Sat Jan 28 02:11:00 CST 2017, time=2017-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861076, encodeId=c5c818610e6b8, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Nov 07 04:11:00 CST 2017, time=2017-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=172047, encodeId=0ea01e2047d8, content=人工智能是亮点, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=635d2010152, createdName=1e1ea464m97(暂无匿称), createdTime=Sun Jan 22 22:53:41 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=172036, encodeId=85aa1e203688, content=学到了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d32a1717978, createdName=1debbfffm06(暂无匿称), createdTime=Sun Jan 22 22:07:38 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489929, encodeId=e91614899294c, content=<a href='/topic/show?id=f91c93134e' target=_blank style='color:#2F92EE;'>#IBM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9313, encryptionId=f91c93134e, topicName=IBM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0288649873, createdName=tulenzi, createdTime=Sun Jan 22 05:11:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525862, encodeId=33551525862f1, content=<a href='/topic/show?id=22a03480efa' target=_blank style='color:#2F92EE;'>#医疗保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34807, encryptionId=22a03480efa, topicName=医疗保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eb511671747, createdName=drj2007, createdTime=Sun Jan 22 05:11:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621592, encodeId=0b99162159265, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sun Jan 22 05:11:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171624, encodeId=8b691e1624e8, content=区块链(Blockchain)是分布式数据存储、点对点传输、共识机制、加密算法等计算机技术的新型应用模式, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri Jan 20 16:03:17 CST 2017, time=2017-01-20, status=1, ipAttribution=)]
  10. [GetPortalCommentsPageByObjectIdResponse(id=2068224, encodeId=7d5c20682243e, content=<a href='/topic/show?id=e94b298327' target=_blank style='color:#2F92EE;'>#ATS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2983, encryptionId=e94b298327, topicName=ATS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Mon Jul 31 14:11:00 CST 2017, time=2017-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719640, encodeId=6f3c1e19640d0, content=<a href='/topic/show?id=1dc333e5881' target=_blank style='color:#2F92EE;'>#区块链#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33758, encryptionId=1dc333e5881, topicName=区块链)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a532785563, createdName=zzc2222, createdTime=Mon Sep 04 14:11:00 CST 2017, time=2017-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1991384, encodeId=e36d1991384ea, content=<a href='/topic/show?id=f51f1861818' target=_blank style='color:#2F92EE;'>#Watson#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18618, encryptionId=f51f1861818, topicName=Watson)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e30378, createdName=caobinglei8079, createdTime=Sat Jan 28 02:11:00 CST 2017, time=2017-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861076, encodeId=c5c818610e6b8, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Nov 07 04:11:00 CST 2017, time=2017-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=172047, encodeId=0ea01e2047d8, content=人工智能是亮点, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=635d2010152, createdName=1e1ea464m97(暂无匿称), createdTime=Sun Jan 22 22:53:41 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=172036, encodeId=85aa1e203688, content=学到了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d32a1717978, createdName=1debbfffm06(暂无匿称), createdTime=Sun Jan 22 22:07:38 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489929, encodeId=e91614899294c, content=<a href='/topic/show?id=f91c93134e' target=_blank style='color:#2F92EE;'>#IBM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9313, encryptionId=f91c93134e, topicName=IBM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0288649873, createdName=tulenzi, createdTime=Sun Jan 22 05:11:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525862, encodeId=33551525862f1, content=<a href='/topic/show?id=22a03480efa' target=_blank style='color:#2F92EE;'>#医疗保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34807, encryptionId=22a03480efa, topicName=医疗保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eb511671747, createdName=drj2007, createdTime=Sun Jan 22 05:11:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621592, encodeId=0b99162159265, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sun Jan 22 05:11:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171624, encodeId=8b691e1624e8, content=区块链(Blockchain)是分布式数据存储、点对点传输、共识机制、加密算法等计算机技术的新型应用模式, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri Jan 20 16:03:17 CST 2017, time=2017-01-20, status=1, ipAttribution=)]
    2017-01-20 三生有幸9135

    区块链(Blockchain)是分布式数据存储、点对点传输、共识机制、加密算法等计算机技术的新型应用模式

    0

相关资讯

FDA警告:MRI检查时请注意患者的可植入型灌输泵

昨日,美国食品和药物管理局(FDA)提出安全警告:FDA已收到关于使用可植入型灌输泵(implantable infusion pumps)的患者在磁共振环境中的严重不良事件报告,甚至有患者受伤及死亡。该报告包括药物剂量无法准确供给(包括输液过荷或不足或不稳定),而且泵会出现机械问题,如电机堵转或者在MRI后泵无法重新启动。FDA介绍说:“磁共振环境原本就对可植入型灌输泵患者存在安全隐患。只有标记

FDA批准两款糖尿病新药组合

近日,美国FDA批准了两款2型糖尿病新药组合,这两款药物均为每天注射一次的长效胰岛素与胰高血糖素样肽-1(GLP-1)类似物组合,针对单独使用胰岛素或GLP-1类似物不能有效控制血糖的患者,它们分别来自法国药企赛诺菲(Sanofi)和丹麦药企诺和诺德(Novo Nordisk)。 2型糖尿病占了糖尿病患者的绝大多数,在全球有2亿多名患者。2型糖尿病的发病因素主要与不健康的生活方式有关,包括肥胖、运

Nature:详解FDA批准的45款肿瘤靶向药物(名称、适应症、靶点、副反应、价格&注意事项)

Nature Review近期发表文章,盘点了迄今为止所有获FDA批准的抗肿瘤靶向药,并详细介绍了它们的名称、适应症、靶点、一般副反应、严重副反应和价格&注意事项。 所谓癌症分子靶向治疗(Molecular targeted cancer therapy,TCT),是在细胞分子水平上,针对已经明确的致癌位点(该位点可以是肿瘤细胞内部的一个蛋白分子,也可以是一个基因片段),来设计相应的

取代医生?FDA批准人工智能分析心脏图像

总部位于美国旧金山的Arterys是一家在基于云的医学成像软件行业领先的公司,其致力于通过强大的云计算工具来处理大量的数据以改变现有的诊断流程,帮助医生更快和更准确地决定治疗方案。近日,Arterys公司旗下的产品Arterys Cardio DL获得FDA批准,用于分析心脏核磁共振图像。这是FDA批准的第一个用于临床的基于云计算和深度学习的分析软件。这也是该软件继去年12月在欧洲获批后达到的又一

FDA局长发话了,基因编辑产品要这么管

基因疗法也好,CRISPR技术也好,和基因编辑相关的产品是未来的发展方向,而这也给FDA的监管带来了新的挑战——毫无疑问,为了让这些产品顺利上市,更精准的监管政策是必须的。近日,美国FDA局长Robert Califf博士和FDA政策办公室的高级政策顾问Ritu Nalubola博士在官方博客上发表长文,对这个问题进行了详细探讨。以下是全文的主要内容。 近期科学的进步让我们可以准确有

长达18页的FDA《2016年度新药审批报告》出炉咯!

导读:众所周知,2016年FDA药品审评与研究中心(CDER)共批准22个原创新药(novel drug),包括15个新分子实体和7个新生物制品。如往年一样,CDER发布了《2016年度新药审批报告》,它不仅报告批准的新药数,而且还聚焦于这些新药的医疗价值、对增强患者医疗保健的贡献以及CDER用于帮助确保这些产品安全、有效研发和审批的多种监管工具。

Baidu
map
Baidu
map
Baidu
map